Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vistagen Therapeutics, Inc. | 14,100 | reported | 06 Sept 2024 | tx 35+1,346,600−160,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Sept 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 14,100 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 18 Aug 2022 | PURCHASE | Vistagen Therapeutics, Inc. | 100,000 | 0.18 USD | |
| 18 Aug 2022 | PURCHASE | Vistagen Therapeutics, Inc. | 100,000 | 0.18 USD | first after silence |
| 01 Mar 2022 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 30 Dec 2020 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 23 Apr 2020 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 21 Oct 2019 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 23 May 2019 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 29 Aug 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | OTHER | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | OTHER | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 29 Aug 2018 | OTHER | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 29 Aug 2018 | OTHER | Vistagen Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 05 Aug 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 02 Feb 2018 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 19 Sept 2017 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 31 May 2017 | PURCHASE | Vistagen Therapeutics, Inc. | 50,000 | — | |
| 31 May 2017 | PURCHASE | Vistagen Therapeutics, Inc. | 50,000 | — | |
| 31 May 2017 | PURCHASE | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 31 May 2017 | PURCHASE | Vistagen Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 26 Apr 2017 | GRANT_AWARD | Vistagen Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 18 Aug 2022.